Clinical Trial Update: Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C [Phase 4]

View source ↗

Summary

Phase 4 trial update examining serum alpha-fetoprotein levels and response to direct antiviral therapy in chronic hepatitis C patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Hepatitis C | Phase 4 | Status: UNKNOWN